John Somberg to Drug-Related Side Effects and Adverse Reactions
This is a "connection" page, showing publications John Somberg has written about Drug-Related Side Effects and Adverse Reactions.
Connection Strength
2.696
-
Evaluating Serious Adverse Drug Reactions. Cardiology. 2018; 139(3):202.
Score: 0.632
-
Screening drugs for QT prolongation. Am J Ther. 2007 Sep-Oct; 14(5):419-20.
Score: 0.306
-
The drug safety review process. Am J Ther. 2007 Mar-Apr; 14(2):119.
Score: 0.296
-
The report of the Institute of Medicine on drug safety. Am J Ther. 2007 Jan-Feb; 14(1):1-2.
Score: 0.292
-
The hypertension peril and drug development. Am J Ther. 2007 Jan-Feb; 14(1):2.
Score: 0.292
-
The new drug evaluation process: risk benefit ratio. Am J Ther. 2005 May-Jun; 12(3):199-200.
Score: 0.260
-
Genetic polymorphisms. Am J Ther. 2002 Jul-Aug; 9(4):271.
Score: 0.214
-
Proposed accelerated FDA approvals for special medical use. Am J Ther. 2012 Nov; 19(6):393-4.
Score: 0.109
-
The human microbiome and therapeutics. Am J Ther. 2012 Jul; 19(4):247.
Score: 0.107
-
Flecainide: safety and efficacy. Cardiology. 2008; 111(2):82.
Score: 0.080
-
Restricting physician prescribing. Am J Ther. 2002 Sep-Oct; 9(5):369.
Score: 0.054
-
Old drugs, new bottles, therapeutic advantage? Am J Ther. 2002 Jul-Aug; 9(4):273-4.
Score: 0.053